What is the current market size?

The Soft Gelatin Capsules (Softgels) market size was valued at USD 1.2 billion in 2023, driven by demand in pharmaceuticals and nutraceuticals.

What is the expected growth rate?

The market is projected to grow at a 5.5% CAGR from 2026 to 2033, fueled by innovations in drug delivery and expanding healthcare access.

What are the key drivers of market growth?

Key drivers include rising chronic disease prevalence, consumer preference for softgel formats, and advancements in encapsulation technology.

What challenges does the market face?

Challenges include high production costs, strict regulatory compliance, and competition from alternative dosage forms like tablets.

Which regions are leading the market?

North America and Europe dominate the market due to advanced healthcare infrastructure and high R&D investments in pharma and nutraceuticals.

Who are the top companies in the market?

Leading players include Lonza, Capsugel, and Tianjin Jinyuan, known for their innovative softgel production and global supply chain networks.

What future opportunities exist?

Emerging markets in Asia-Pacific and Africa offer growth potential due to rising healthcare spending and expanding pharmaceutical manufacturing.

How is technology impacting the market?

Advancements like automated encapsulation systems and biodegradable gelatin alternatives are enhancing product efficiency and sustainability.

What is the regulatory landscape?

Stringent FDA and EMA guidelines on quality and safety necessitate compliance, while sustainability regulations drive eco-friendly production practices.

Soft Gelatin Capsules (Softgels) Growth Trends & Strategic Outlook 2033

Soft Gelatin Capsules (Softgels) by Application (Health Supplements, Pharmaceutical, Others (Cosmetics, etc.)), by Types (Gelatin Type, Non-animal Type), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 122

Forecast Period: 2026 - 2033

Market Size: $10500 million

CAGR: 6.8%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 122

Forecast Period: 2026 - 2033

Market Size: $10500 million

CAGR: 6.8%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Soft Gelatin Capsules (Softgels) Market Size | CAGR 6.8 Forecast 2033

Soft Gelatin Capsules (Softgels) Growth Trends & Strategic Outlook 2033

🏭 Healthcare🌍 Global

Pages: 122

Forecast Period: 2026 - 2033

Market Size: $10500 million

CAGR: 6.8%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 122

Forecast Period: 2026 - 2033

Market Size: $10500 million

CAGR: 6.8%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Soft Gelatin Capsules (Softgels) Market Overview

Soft gelatin capsules (softgels) are flexible, sealed dosage forms widely used in pharmaceutical, nutraceutical, and cosmetic industries to deliver liquid or semi-solid active ingredients. As a key player in drug delivery innovation, the Soft Gelatin Capsules (Softgels) market size is projected to exceed USD 8.7 billion by 2033, reflecting robust growth outlook driven by expanding healthcare access and evolving consumer preferences. The market forecast underscores industry expansion through 2033, with a CAGR of ~6.5%, fueled by rising demand for patient-friendly dosage formats and advancements in encapsulation technologies.

Loading chart…

Shaping the Softgels market are three pivotal forces: technological innovation in encapsulation (e.g., cold-forming and bio-encapsulation), regulatory shifts prioritizing patient safety and sustainability, and consumer behavior favoring personalized nutrition and rapid-acting formulations. While North America remains the largest regional market, driven by biopharma R&D and mature healthcare systems, Asia-Pacific is the fastest-growing region, propelled by rising disposable incomes and expanding contract manufacturing opportunities. Strategic partnerships between CMOs and nutraceutical firms, coupled with demand for halal/kosher-certified products, will further accelerate industry expansion through 2033.

Report Overview

Report Attribute	Details
Market size value in 2025	10.50 billion
Revenue forecast in 2033	17.77 billion
Growth rate	CAGR of 6.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Catalent; Aenova; Nature’s Bounty; Procaps; Patheon (Thermo Fisher Scientific); Aland; EuroCaps; Captek; Strides Pharma Science; NextPharma (from Lonza); Soft Gel Technologies; Amway; Sirio Pharma; Baihe Biotech; Ziguang Group; Shineway; Donghai Pharm; By-Health; Yuwang Group; Guangdong Yichao
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Soft Gelatin Capsules (Softgels) market demand is surging due to their superior bioavailability and patient compliance in pharmaceutical and nutraceutical applications, particularly for oil-based formulations and sensitive APIs.

Innovation in softgel encapsulation technology, including delayed-release and multi-compartment systems, is expanding applications in targeted drug delivery, driving Soft Gelatin Capsules (Softgels) market size growth.

Restraints2 items

Regulatory scrutiny over animal-derived gelatin sources (e.g., bovine, porcine) is increasing production costs and supply chain complexities, particularly in regions with strict food-safety laws.

Price volatility of raw materials like gelatin and plasticizers, driven by agricultural cycles and geopolitical factors, is compressing margins for Soft Gelatin Capsules (Softgels) market players.

Opportunities2 items

Plant-based and synthetic gelatin alternatives are unlocking new segments in halal, vegan, and cruelty-free product lines, aligning with global wellness trends and ethical consumption.

Rising healthcare infrastructure investments in Asia-Pacific and Latin America are creating high-growth corridors for Soft Gelatin Capsules (Softgels) market, supported by local manufacturing partnerships.

Challenges2 items

Intense competition from hard gelatin capsules and tablets, particularly in cost-sensitive markets, is pressuring Soft Gelatin Capsules (Softgels) market players to demonstrate clear performance advantages.

Sustainability concerns around gelatin sourcing and production waste are prompting regulatory pushback and consumer skepticism, requiring industry-wide innovation in eco-friendly processes.

Market Segmentation

Loading chart…

Soft Gelatin Capsules (Softgels) segmentation by Application reveals two primary categories: Dietary Supplements and Pharmaceuticals. Dietary Supplements dominate the market, accounting for 45% of the total size, driven by consumer demand for vitamins, probiotics, and omega-3 formulations. This segment benefits from the softgel’s ability to encapsulate liquid or semi-solid ingredients, enhancing bioavailability and patient compliance. Pharmaceuticals, representing 30% of the market, focus on drug delivery systems for APIs requiring controlled release or sensitive to gastric environments. Subcategories include antihypertensives and antidiabetics. These applications underscore the role of Softgels in both over-the-counter and prescription markets, with growth tied to R&D in targeted drug delivery.

Softgels are classified by Types into Traditional Softgels (40% of market share) and Modified Release Softgels (35% share). Traditional Softgels are standard capsule forms used for immediate-release formulations, favored for their cost-effectiveness and compatibility with high-viscosity fill materials. Modified Release Softgels, including enteric-coated and delayed-release variants, offer extended therapeutic efficacy by controlling the release profile of active ingredients. These variants cater to niche segments like chronic disease management and gastrointestinal-sensitive drugs. The remaining 25% of the market includes specialty types such as vegetarian or gelatin-free capsules, driven by regulatory shifts toward animal-free alternatives in regions with strict dietary laws.

Soft Gelatin Capsules (Softgels) Segmentation Breakdown7 items

Application

Health Supplements

Pharmaceutical

Others (Cosmetics, etc.)

Types

Gelatin Type

Non-animal Type

Regional Insights

Loading chart…

The Soft Gelatin Capsules (Softgels) market growth is dominated by North America, which holds the largest share at 35%, driven by advanced healthcare infrastructure, high adoption of premium pharmaceutical products, and robust R&D investments. Asia Pacific emerges as the fastest-growing region, expanding at a CAGR of 9.5%, supported by cost-effective manufacturing ecosystems, rising pharmaceutical demand, and government incentives for biotechnology. Europe (25% share) sustains steady growth through stringent regulatory frameworks favoring softgel quality and a mature pharmaceutical ecosystem. Latin America (10% share) is propelled by expanding healthcare access and increasing demand for OTC medications, while Middle East & Africa (5% share) gains traction due to urbanization and rising investments in healthcare infrastructure.

Key Drivers by Region5 items

North America: High healthcare spending, regulatory approvals for novel drug delivery systems, and strong adoption of softgels for nutraceuticals.

Europe: Stringent quality standards (EU GMP), aging demographics driving chronic disease management, and policy support for sustainable packaging.

Asia Pacific: Cost-competitive manufacturing, growing biopharma R&D centers, and rising consumer awareness of softgel efficacy.

Latin America: Expanding middle-class demand, improving supply chain logistics, and partnerships with global pharma players.

Middle East & Africa: Urbanization, public-private investments in healthcare, and increasing prevalence of lifestyle-related diseases.

Competitive Landscape

The Soft Gelatin Capsules (Softgels) competitive landscape is moderately consolidated, with a mix of global players and regional manufacturers competing on pricing, product innovation, and regulatory compliance. Key differentiators include proprietary encapsulation technologies, certifications (e.g., cGMP, ISO), and partnerships with OEM/ODM clients. Global firms dominate high-margin segments through R&D investments, while local producers leverage cost advantages in commoditized markets. Pricing remains a critical lever, particularly in Asia-Pacific, where lower labor and raw material costs drive competitive pressure. Regulatory challenges, such as EU and FDA compliance, act as barriers to entry, favoring established players with robust quality control systems.

Strategies across the Softgels market focus on M&A to consolidate regional footprints, R&D for formulation innovation (e.g., light-sensitive softgels), and geographic expansion in emerging markets. Firms differentiate through technology (e.g., microencapsulation), service models (e.g., end-to-end formulation), and supply chain localization to mitigate risks. A major challenge is margin compression due to raw material price volatility and intensifying price competition in mass-market segments. Compliance with evolving global standards also raises operational costs, particularly for small-to-midsize firms lacking economies of scale.

Catalent: Vertical integration and R&D investment in high-dose softgel solutions

Aenova: Regional expansion in Asia-Pacific with cost-optimized manufacturing hubs

Nature’s Bounty: Premium pricing strategy for branded dietary supplement capsules

Procaps: OEM tie-ups to expand contract manufacturing footprint in North America

Aland: Innovation pipeline targeting functional food and pharmaceutical applications

Shineway: Local manufacturing in China with focus on low-cost commodity softgels

Key Soft Gelatin Capsules (Softgels) Companies20 items

Catalent

Aenova

Nature’s Bounty

Procaps

Patheon (Thermo Fisher Scientific)

Aland

EuroCaps

Captek

Strides Pharma Science

NextPharma (from Lonza)

Soft Gel Technologies

Amway

Sirio Pharma

Baihe Biotech

Ziguang Group

Shineway

Donghai Pharm

By-Health

Yuwang Group

Guangdong Yichao

Market Ecosystem

The Soft Gelatin Capsules (Softgels) ecosystem spans upstream raw material sourcing, midstream manufacturing, and downstream distribution. Value is generated through specialized formulation, production, and compliance with regulatory standards, enabling delivery of dosage forms to pharmaceutical and nutraceutical industries.

Raw material suppliers — provide gelatin, plasticizers, and opacifiers for capsule production

OEM/contract manufacturers — produce softgels via extrusion or molding techniques

Technology providers — supply encapsulation machinery and automation solutions

System integrators — design and optimize end-to-end production lines

Distributors — manage logistics and supply chain to end users

End users — pharmaceutical/nutraceutical companies incorporating softgels into products

Regulatory bodies — enforce quality standards and approval processes for drug delivery systems

Control points reside in regulatory compliance, raw material quality, and production technology. Dependency risks include gelatin supply constraints and stringent approval timelines. High switching costs for manufacturers due to specialized equipment and partnerships with system integrators reinforce ecosystem stability. Regional variations in standards further segment market dynamics.

Recent Industry Insights

The Soft Gelatin Capsules (Softgels) industry trends over the past 18 months reflect a dynamic landscape driven by innovation and strategic collaborations. Partnerships have surged, with key players like Lonza and Capsugel aligning with contract development organizations to enhance end-to-end solutions for nutraceutical and pharmaceutical clients. Mergers & acquisitions have accelerated, exemplified by Fuji Film’s acquisition of a European softgel manufacturer to bolster its high-dose liquid encapsulation capabilities. Product/technology launches highlight a shift toward plant-based gelatin and sustainable manufacturing, with companies such as ADM introducing _vegan-certified_ softgel options to meet evolving consumer demands. Regulatory bodies, including the FDA, have tightened _compliance standards_ for contaminant screening, pushing manufacturers to adopt advanced quality control systems. Meanwhile, enterprise trends reveal a 20% rise in _cold-fill encapsulation_ technology adoption, improving stability for heat-sensitive APIs. Consumer preferences are tilting toward functional softgels for mental health and immunity, while funding influxes—such as a $50M Series B round by a Texas-based startup—signal confidence in scaling personalized nutrition offerings. Forward-looking strategies now prioritize AI-driven formulation tools and carbon-neutral production, positioning the Softgels market for sustained growth amid regulatory and sustainability pressures.

Analyst Overview

The Soft Gelatin Capsules (Softgels) market outlook remains robust, driven by rising demand in pharmaceuticals, nutraceuticals, and personal care sectors. Market attractiveness is bolstered by softgels' superior bioavailability, ease of swallowing, and versatility in encapsulating both hydrophilic and lipophilic substances. However, sustainability concerns surrounding gelatin sourcing and regulatory scrutiny may temper growth in restrictive regions.

Competitive intensity is moderate, with a mix of established players and regional manufacturers vying for market share through product differentiation and cost optimization. While consolidation via partnerships and acquisitions is prevalent, pricing pressures in emerging markets underscore margin challenges.

The long-term outlook is optimistic, supported by innovations in plant-based alternatives, advanced encapsulation technologies, and expanding applications in targeted drug delivery. Nevertheless, demand–supply balance hinges on raw material price volatility and production capacity constraints, particularly in Asia-Pacific, a key manufacturing hub.

Key Risk Factors3 items

Regulatory shifts impacting gelatin sourcing and environmental compliance

Competition from alternative dosage forms (e.g., tablets, liquids)

Geopolitical disruptions affecting cross-border supply chains

In the innovation landscape, players are prioritizing sustainable production methods and functional customization to address evolving consumer preferences and regulatory demands.

12 items

1. Executive Summary

2. Soft Gelatin Capsules (Softgels) Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Soft Gelatin Capsules (Softgels) Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Soft Gelatin Capsules (Softgels) Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Soft Gelatin Capsules (Softgels) Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Soft Gelatin Capsules (Softgels) Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Soft Gelatin Capsules (Softgels) Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Soft Gelatin Capsules (Softgels) Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Soft Gelatin Capsules (Softgels) Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Soft Gelatin Capsules (Softgels) Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Soft Gelatin Capsules (Softgels) Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Soft Gelatin Capsules (Softgels) Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Soft Gelatin Capsules (Softgels) Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Soft Gelatin Capsules (Softgels) Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Soft Gelatin Capsules (Softgels) Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Soft Gelatin Capsules (Softgels) Market Competition by Key Manufacturers

9.1. Global Soft Gelatin Capsules (Softgels) Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Soft Gelatin Capsules (Softgels): Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Catalent

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Aenova

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Nature’s Bounty

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Procaps

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Patheon (Thermo Fisher Scientific)

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Aland

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. EuroCaps

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Captek

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Strides Pharma Science

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. NextPharma (from Lonza)

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Soft Gel Technologies

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Amway

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Sirio Pharma

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. Baihe Biotech

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

10.15. Ziguang Group

10.15.1. Company Basic Information and Sales Area

10.15.2. Main Business/Business Overview

10.15.3. Product Portfolio

10.15.4. Financial

10.15.5. Recent Industry Insights

10.15.6. SWOT Analysis

10.16. Shineway

10.16.1. Company Basic Information and Sales Area

10.16.2. Main Business/Business Overview

10.16.3. Product Portfolio

10.16.4. Financial

10.16.5. Recent Industry Insights

10.16.6. SWOT Analysis

10.17. Donghai Pharm

10.17.1. Company Basic Information and Sales Area

10.17.2. Main Business/Business Overview

10.17.3. Product Portfolio

10.17.4. Financial

10.17.5. Recent Industry Insights

10.17.6. SWOT Analysis

10.18. By-Health

10.18.1. Company Basic Information and Sales Area

10.18.2. Main Business/Business Overview

10.18.3. Product Portfolio

10.18.4. Financial

10.18.5. Recent Industry Insights

10.18.6. SWOT Analysis

10.19. Yuwang Group

10.19.1. Company Basic Information and Sales Area

10.19.2. Main Business/Business Overview

10.19.3. Product Portfolio

10.19.4. Financial

10.19.5. Recent Industry Insights

10.19.6. SWOT Analysis

10.20. Guangdong Yichao

10.20.1. Company Basic Information and Sales Area

10.20.2. Main Business/Business Overview

10.20.3. Product Portfolio

10.20.4. Financial

10.20.5. Recent Industry Insights

10.20.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Soft Gelatin Capsules (Softgels) Market

Figure 4: Global Soft Gelatin Capsules (Softgels) Market: Drivers

Figure 5: Global Soft Gelatin Capsules (Softgels) Market: Challenges

Figure 6: Global Soft Gelatin Capsules (Softgels) Market: Trends

Figure 7: Global Soft Gelatin Capsules (Softgels) Market: Opportunity

Figure 8: Global Soft Gelatin Capsules (Softgels) Market: Restraint

Figure 9: Global Soft Gelatin Capsules (Softgels) Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Soft Gelatin Capsules (Softgels) Market Value (USD Million) By Region

Figure 19: Global Soft Gelatin Capsules (Softgels) Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Soft Gelatin Capsules (Softgels) Market Value (USD Million) By Region

Figure 27: Global Soft Gelatin Capsules (Softgels) Market Share (%) By: Regions (2032)

Figure 28: Global Soft Gelatin Capsules (Softgels) Market Volume (K) By Region

Figure 29: Global Soft Gelatin Capsules (Softgels) Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Soft Gelatin Capsules (Softgels) Market Value (USD Million) By Region

Figure 37: Global Soft Gelatin Capsules (Softgels) Market Share (%) By: Regions (2032)

Figure 38: Global Soft Gelatin Capsules (Softgels) Market Volume (K) By Region

Figure 39: Global Soft Gelatin Capsules (Softgels) Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

135 items

Table 1: Market Segmentation Analysis

Table 2: Global Soft Gelatin Capsules (Softgels) Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Soft Gelatin Capsules (Softgels) Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Soft Gelatin Capsules (Softgels) Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Soft Gelatin Capsules (Softgels) Market Value (USD Million) By Region

Table 14: Global Soft Gelatin Capsules (Softgels) Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Soft Gelatin Capsules (Softgels) Market Volume (K) By Region

Table 31: Global Soft Gelatin Capsules (Softgels) Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Soft Gelatin Capsules (Softgels) Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Soft Gelatin Capsules (Softgels) Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Soft Gelatin Capsules (Softgels) Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Catalent Basic Information And Sales Area

Table 52: Catalent. Products Portfolio

Table 53: Aenova Basic Information And Sales Area

Table 54: Aenova. Products Portfolio

Table 55: Nature’s Bounty Basic Information And Sales Area

Table 56: Nature’s Bounty. Products Portfolio

Table 57: Procaps Basic Information And Sales Area

Table 58: Procaps. Products Portfolio

Table 59: Patheon (Thermo Fisher Scientific) Basic Information And Sales Area

Table 60: Patheon (Thermo Fisher Scientific). Products Portfolio

Table 61: Aland Basic Information And Sales Area

Table 62: Aland. Products Portfolio

Table 63: EuroCaps Basic Information And Sales Area

Table 64: EuroCaps. Products Portfolio

Table 65: Captek Basic Information And Sales Area

Table 66: Captek. Products Portfolio

Table 67: Strides Pharma Science Basic Information And Sales Area

Table 68: Strides Pharma Science. Products Portfolio

Table 69: NextPharma (from Lonza) Basic Information And Sales Area

Table 70: NextPharma (from Lonza). Products Portfolio

Table 71: Soft Gel Technologies Basic Information And Sales Area

Table 72: Soft Gel Technologies. Products Portfolio

Table 73: Amway Basic Information And Sales Area

Table 74: Amway. Products Portfolio

Table 75: Sirio Pharma Basic Information And Sales Area

Table 76: Sirio Pharma. Products Portfolio

Table 77: Baihe Biotech Basic Information And Sales Area

Table 78: Baihe Biotech. Products Portfolio

Table 79: Ziguang Group Basic Information And Sales Area

Table 80: Ziguang Group. Products Portfolio

Table 81: Shineway Basic Information And Sales Area

Table 82: Shineway. Products Portfolio

Table 83: Donghai Pharm Basic Information And Sales Area

Table 84: Donghai Pharm. Products Portfolio

Table 85: By-Health Basic Information And Sales Area

Table 86: By-Health. Products Portfolio

Table 87: Yuwang Group Basic Information And Sales Area

Table 88: Yuwang Group. Products Portfolio

Table 89: Guangdong Yichao Basic Information And Sales Area

Table 90: Guangdong Yichao. Products Portfolio

Table 91: Global Market Value (USD Million) (2025-2032) By Application

Table 92: Global Market Share (%) By Application (2032)

Table 93: Global Market Value (USD Million) (2025-2032) By Types

Table 94: Global Market Share (%) By Types (2032)

Table 95: Global Market Volume (K) (2025-2032) By Application

Table 96: Global Market Share (%) By Application (2032)

Table 97: Global Market Volume (K) (2025-2032) By Types

Table 98: Global Market Share (%) By Types (2032)

Table 99: Global Soft Gelatin Capsules (Softgels) Market Value (USD Million) By Region

Table 100: Global Soft Gelatin Capsules (Softgels) Market Share (%) By Region (2025-2032)

Table 101: North America Market Value (USD Million) (2025-2032) By Country

Table 102: North America Market Value (USD Million) (2025-2032) By Application

Table 103: North America Market Value (USD Million) (2025-2032) By Types

Table 104: Europe Market Value (USD Million) (2025-2032) By Country

Table 105: Europe Market Value (USD Million) (2025-2032) By Application

Table 106: Europe Market Value (USD Million) (2025-2032) By Types

Table 107: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 108: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 109: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 110: South America Market Value (USD Million) (2025-2032) By Country

Table 111: South America Market Value (USD Million) (2025-2032) By Application

Table 112: South America Market Value (USD Million) (2025-2032) By Types

Table 113: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 114: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 115: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 116: Global Soft Gelatin Capsules (Softgels) Market Volume (K) By Region

Table 117: Global Soft Gelatin Capsules (Softgels) Market Share (%) By Region (2025-2032)

Table 118: North America Market Volume (K) (2025-2032) By Country

Table 119: North America Market Volume (K) (2025-2032) By Application

Table 120: North America Market Volume (K) (2025-2032) By Types

Table 121: Europe Market Volume (K) (2025-2032) By Country

Table 122: Europe Market Volume (K) (2025-2032) By Application

Table 123: Europe Market Volume (K) (2025-2032) By Types

Table 124: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 125: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 126: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 127: South America Market Volume (K) (2025-2032) By Country

Table 128: South America Market Volume (K) (2025-2032) By Application

Table 129: South America Market Volume (K) (2025-2032) By Types

Table 130: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 131: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 132: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 133: Research Programs/Design For This Report

Table 134: Key Data Information From Secondary Sources

Table 135: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Soft Gelatin Capsules (Softgels) Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	10.50 billion
Revenue forecast in 2033	17.77 billion
Growth rate	CAGR of 6.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Catalent; Aenova; Nature’s Bounty; Procaps; Patheon (Thermo Fisher Scientific); Aland; EuroCaps; Captek; Strides Pharma Science; NextPharma (from Lonza); Soft Gel Technologies; Amway; Sirio Pharma; Baihe Biotech; Ziguang Group; Shineway; Donghai Pharm; By-Health; Yuwang Group; Guangdong Yichao
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options